Collier R.Prevalence of ghostwriting spurs calls for transparency Canadian Medical Association Journal. 2009;13; 181(8): E161–E162. doi: 10.1503/cmaj.109-3036 ... prevalent ghost-writing appears to have become. Between 50% and 100% of articles on drugs that appear in journals are said to be ghostwritten,and the effect of ghostwriting on the quality of medical publishing is difficult to assess.

... writing it." So, after yesterday's post about ghostwriting, I stepped on over to How Publishing Really Works to read the sad, ... unethical ghostwriter/agent. Now, this is a sad tale, but I do think that ghostwriting is a good way to make money. Technical writers ... Read this excellent interview with Bob Olsen on ghostwriting, and how it can be lucrative and an idea fit for wrters who are shy ...

... Senate Finance Committee, sent the letters as part of his continuing investigation of so-called medical ghostwriting. The term refers to publication of medical journal articles in which an outside writer — ... , one or more academic researchers may receive author credit. Mr. Grassley said ghostwriting had hurt patients and raised costs for taxpayers because it used prestigious academic names to ...

To Senator Charles Grassley (R-IA) ghostwriting and plagiarism fall within the same arena of misdeed. To some bioethicists that distinction is not so clear cut. Without a doubt, ... he chairs in the Senate are doing the medical profession a great service by exposing the practice of medical ghostwriting — the publication of medical journal articles in which an outside writer (oftentimes paid by a ...

... . (Oops, they assumed the economist's results would be unfavorable.) Isn't this like a drugmaker drafting a medical study and then shopping around for a doctor to put his or her name on it? Ghostwriting is a huge problem for the credibility of peer reviewed studies, so why would this be any different? Should we hold economic research to the same standards as other scientific research? No ...

... who is a leading critic of conflicts of interest in biomedical research, is focusing on the issue of journal ghostwriting. The New York Times reported that he has written to 10 medical schools, asking about whether they have policies that deal with issues raised by pharmaceutical companies ghostwriting articles that appear under the names of university researchers.